Board recommends Final Dividend
Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2013, inter alia, has recommended Final dividend of Rs. 29 per Equity share of Rs. 10 for the year ended December 31, 2012. Financial Results for Dec 31, 2012
Sanofi India Ltd has informed BSE about the Financial Results for the period ended December 31, 2012. Resignation of Director
Sanofi India Ltd has informed BSE that Mr. S. Umesh has resigned as Alternate Director / Wholetime Director of the Company with effect from February 01, 2013 as he is taking up a position in the Sanofi Group in France. Sanofi India launches Combiflam Plus
Sanofi India Ltd has informed BSE regarding a Press Release dated February 14, 2013, titled "Sanofi India launches Combiflam Plus" Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Sanofi India Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Sanofi India Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Life Insurance Corporation of India has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Limited Review for Sep 30, 2012
Sanofi India Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended September 30, 2012. Financial Results for Sep 30, 2012
Sanofi India Ltd has informed BSE about the Financial Results for the period ended September 30, 2012.